Osamu Oikawa

471 total citations
21 papers, 365 citations indexed

About

Osamu Oikawa is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Osamu Oikawa has authored 21 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in Osamu Oikawa's work include Dialysis and Renal Disease Management (10 papers), Erythropoietin and Anemia Treatment (3 papers) and Chronic Kidney Disease and Diabetes (2 papers). Osamu Oikawa is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Erythropoietin and Anemia Treatment (3 papers) and Chronic Kidney Disease and Diabetes (2 papers). Osamu Oikawa collaborates with scholars based in Japan and United States. Osamu Oikawa's co-authors include Kazuyoshi Okada, Masanori Abe, Kowichi Jimbow, Toshio Yamazaki, Takuji Takeuchi, Terumi Higuchi, Sadao Sugiyama, Masayoshi Soma, Hideyuki Ando and Noboru Fukuda and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Investigative Dermatology and Nutrients.

In The Last Decade

Osamu Oikawa

20 papers receiving 339 citations

Peers

Osamu Oikawa
R Baczyński United States
Wil H.L. Hackeng Netherlands
A. S. Brickman United States
Belgi̇n Efe Türkiye
Hans Thomsen Denmark
Osamu Oikawa
Citations per year, relative to Osamu Oikawa Osamu Oikawa (= 1×) peers Ricardo Kohan

Countries citing papers authored by Osamu Oikawa

Since Specialization
Citations

This map shows the geographic impact of Osamu Oikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Oikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Oikawa more than expected).

Fields of papers citing papers by Osamu Oikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Oikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Oikawa. The network helps show where Osamu Oikawa may publish in the future.

Co-authorship network of co-authors of Osamu Oikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Oikawa. A scholar is included among the top collaborators of Osamu Oikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Oikawa. Osamu Oikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maruyama, Takashi, Terumi Higuchi, Toshio Yamazaki, et al.. (2017). Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia. Cardiorenal Medicine. 7(3). 188–197. 16 indexed citations
2.
Abe, Masanori, Kazuyoshi Okada, Osamu Oikawa, Noriaki Maruyama, & Tetsuya Furukawa. (2016). SP379EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR IN HEMODIALYSIS PATIENTS WITH TYPE 2 DIABETES. Nephrology Dialysis Transplantation. 31(suppl_1). i216–i216. 1 indexed citations
3.
Higuchi, Terumi, Masanori Abe, Mari Mizuno, et al.. (2015). Association of restless legs syndrome with oxidative stress and inflammation in patients undergoing hemodialysis. Sleep Medicine. 16(8). 941–948. 41 indexed citations
4.
Higuchi, Terumi, Masanori Abe, Toshio Yamazaki, et al.. (2015). Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial. American Journal of Kidney Diseases. 67(2). 260–270. 57 indexed citations
5.
Kobayashi, Hiroki, Masanori Abe, Yusuke Murata, et al.. (2015). Low-density lipoprotein apheresis for corticosteroid-resistant skin lesions caused by cholesterol crystal embolism: a case report and review of the literature. Journal of Artificial Organs. 18(3). 285–289. 3 indexed citations
6.
Furukawa, Tetsuya, Kazuyoshi Okada, Masanori Abe, et al.. (2015). Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage. International Journal of Molecular Sciences. 16(12). 30181–30189. 4 indexed citations
7.
Abe, Masanori, Noriaki Maruyama, Osamu Oikawa, et al.. (2015). Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease. Scandinavian Journal of Clinical and Laboratory Investigation. 75(5). 421–427. 7 indexed citations
8.
Abe, Masanori, Kazuyoshi Okada, Noriaki Maruyama, et al.. (2015). Comparison of Clinical Trajectories before Initiation of Renal Replacement Therapy between Diabetic Nephropathy and Nephrosclerosis on the KDIGO Guidelines Heat Map. Journal of Diabetes Research. 2016. 1–9. 15 indexed citations
9.
Abe, Masanori, Osamu Oikawa, Kazuyoshi Okada, & Masayoshi Soma. (2014). Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan. Journal of the Renin-Angiotensin-Aldosterone System. 16(1). 159–164. 25 indexed citations
10.
Higuchi, Terumi, Masanori Abe, Toshio Yamazaki, et al.. (2014). Effects of Levocarnitine on Brachial-Ankle Pulse Wave Velocity in Hemodialysis Patients: A Randomized Controlled Trial. Nutrients. 6(12). 5992–6004. 28 indexed citations
11.
Higuchi, Terumi, Toshio Yamazaki, Yoshihiko Ohnishi, et al.. (2007). A Case Report of Hemodialysis Intolerance With Eosinophilia. Therapeutic Apheresis and Dialysis. 11(1). 70–73. 3 indexed citations
12.
Oikawa, Osamu, Terumi Higuchi, Toshio Yamazaki, et al.. (2007). Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clinical and Experimental Nephrology. 11(4). 304–308. 23 indexed citations
13.
Higuchi, Terumi, Noboru Fukuda, Chii Yamamoto, et al.. (2006). The Influence of Uremic Serum on Interleukin‐1β and Interleukin‐1 Receptor Antagonist Production by Peripheral Blood Mononuclear Cells. Therapeutic Apheresis and Dialysis. 10(1). 65–71. 6 indexed citations
14.
Higuchi, Terumi, Yoshihiro Matsukawa, Kazuyoshi Okada, et al.. (2006). Correction of Copper Deficiency Improves Erythropoietin Unresponsiveness in Hemodialysis Patients with Anemia. Internal Medicine. 45(5). 271–273. 30 indexed citations
15.
Oikawa, Osamu, et al.. (2005). Intracorporeal Ultrafiltration with Icodextrin for the Treatment of Severe Overhydration. Peritoneal Dialysis International. 25(5). 503–503. 3 indexed citations
16.
Oikawa, Osamu, et al.. (2000). Analysis of tractive performance of a rigid wheel using a three dimensional finite element method. Keisan Rikigaku Koenkai koen ronbunshu. 2000.13(0). 693–694.
17.
Oikawa, Osamu, et al.. (1985). EPIDERMODYSPLASIA VERRUCIFORMIS. The Journal of Dermatology. 12(2). 183–190. 3 indexed citations
18.
Jimbow, Kowichi, Osamu Oikawa, Sadao Sugiyama, & Takuji Takeuchi. (1979). Comparison of Eumelanogenesis and Pheomelanogenesis in Retinal and Follicular Melanocytes; Role of Vesculo-globular Bodies in Melanosome Differentiation. Journal of Investigative Dermatology. 73(4). 278–284. 91 indexed citations
19.
Oikawa, Osamu. (1977). The surface movement of soil and organic matter in a Chamaecyparis obtusa stand on the slope. Journal of the Japanese Forest Society. 59(5). 153–158. 7 indexed citations
20.
Uesugi, Takashi, et al.. (1977). [Fine structure of mitotic melanocytes in the epidermis of C57 black mouse after UV irradiation (UV-A) (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 87(13). 925–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026